Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expression of immune check point gene TIM‑3 in patients newly diagnosed with acute myeloid leukemia: Significance and impact on outcome
Amany M. Kamal, Nermeen Nabih, Nooran S. Elleboudy, et al.
Oncology Letters (2021) Vol. 21, Iss. 4
Open Access | Times Cited: 18

Showing 18 citing articles:

Catch me if you can: how AML and its niche escape immunotherapy
Sarah Tettamanti, Alice Pievani, Andrea Biondi, et al.
Leukemia (2021) Vol. 36, Iss. 1, pp. 13-22
Open Access | Times Cited: 131
The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways
Maryam Bakhtiyari, Mahsa Liaghat, Fatemeh Aziziyan, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 31
Immune checkpoints and cancer immunotherapies: insights into newly potential receptors and ligands
Alí N. Kamali, José M. Bautista, Michael Eisenhut, et al.
Therapeutic Advances in Vaccines and Immunotherapy (2023) Vol. 11
Open Access | Times Cited: 20
Genetic signature of CTLA-4, BTLA, TIM-3 and LAG-3 molecular expression in colorectal cancer patients: Implications in diagnosis and survival outcomes
Amany M. Kamal, Eman F. Wasfey, Wesam Reda Elghamry, et al.
Clinical Biochemistry (2021) Vol. 96, pp. 13-18
Closed Access | Times Cited: 31
Immunotherapy in leukaemia
Xingmei Mu, Chumao Chen, Loujie Dong, et al.
Acta Biochimica et Biophysica Sinica (2023) Vol. 55, Iss. 6, pp. 974-987
Open Access | Times Cited: 8
Upregulation of Tim‐3 is associated with poor prognosis in acute myeloid leukemia
Zhengwei Wu, Jiawang Ou, Nannan Liu, et al.
Cancer Medicine (2022) Vol. 12, Iss. 7, pp. 8956-8969
Open Access | Times Cited: 14
Activated Tim-3/Galectin-9 participated in the development of multiple myeloma by negatively regulating CD4 T cells
Rui Zhang, Shuang Chen, Tingting Luo, et al.
Hematology (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 6
The role of circular RNA plasmacytoma variant translocation 1 as a biomarker for prognostication of acute myeloid leukemia
Tao Chen, Fengyun Chen
Hematology (2021) Vol. 26, Iss. 1, pp. 1018-1024
Open Access | Times Cited: 12
TIM-3 Expression Level on AML Blasts Correlates With Presence of Core Binding Factor Translocations Rather Than Clinical Outcomes
Jian Hong, Leiming Xia, Zhenqi Huang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
A T-cell receptor as a promising immunotherapeutic target in acute myeloid leukemia: expression of T cell immunoglobulin and mucin-containing-3 on bone marrow hematopoietic cells
Heba Mohamed Atif, Inas Abdel Moaty Mohamed
The Egyptian Journal of Haematology (2024) Vol. 49, Iss. 1, pp. 83-91
Closed Access | Times Cited: 1
Phenotypic changes of γδ T cells in Plasmodium falciparum placental malaria and pregnancy outcomes in women at delivery in Cameroon
Chris Marco Mbianda Nana, Bodin Darcisse Kwanou Tchakounté, Bernard Marie Zambo Bitye, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Anti-TIM3 chimeric antigen receptor-natural killer cells preferentially target primitive acute myeloid leukemia cells with minimal fratricide and exhaustion
Phatchanat Klaihmon, Parinya Samart, Yon Rojanasakul, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia
Kateřina Kuželová, Barbora Brodská, Jana Marková, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 5
The prospective prognostic value of the immune checkpoint BTLA expression in adult acute myeloid leukemia patients
Sara M. Radwan, Nooran S. Elleboudy, Nermeen Nabih, et al.
Egyptian Journal of Medical Human Genetics (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Natural Killer Cell Cellular-based Therapeutic Options to Manage Acute Myeloid Leukemia: Prospects and Challenges
Ogochukwu Izuegbuna
Deleted Journal (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access
Prognostic impact of T-cell immunoglobulin and mucin domain-3/Galectin-9 expression in acute myeloid leukemia patients
Abdallah H. Fathy, Norhan Mohmed Kamal Eldien Youssef, Deena Samir Eissa, et al.
The Egyptian Journal of Haematology (2024) Vol. 49, Iss. 3, pp. 216-222
Closed Access
Siglec-6 CAR T: magic bullet for a moving target
Sara Ghorashian, Martin Pulé
Blood (2021) Vol. 138, Iss. 19, pp. 1786-1787
Open Access | Times Cited: 1
Natural Killer Cell Cellular–Based Therapeutic Options for Management of Acute Myeloid Leukemia: Prospect and Challenges
Ogochukwu Izuegbuna
(2023)
Open Access
Page 1

Scroll to top